Correlation Between Hookipa Pharma and NextCure
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and NextCure, you can compare the effects of market volatilities on Hookipa Pharma and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and NextCure.
Diversification Opportunities for Hookipa Pharma and NextCure
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hookipa and NextCure is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and NextCure go up and down completely randomly.
Pair Corralation between Hookipa Pharma and NextCure
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the NextCure. In addition to that, Hookipa Pharma is 1.33 times more volatile than NextCure. It trades about -0.02 of its total potential returns per unit of risk. NextCure is currently generating about 0.01 per unit of volatility. If you would invest 162.00 in NextCure on August 28, 2024 and sell it today you would lose (42.00) from holding NextCure or give up 25.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. NextCure
Performance |
Timeline |
Hookipa Pharma |
NextCure |
Hookipa Pharma and NextCure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and NextCure
The main advantage of trading using opposite Hookipa Pharma and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |